Sub-retinal implant

Default banner image for Sub-retinal implant
Photo of Colin Kerr

Pixium Vision has announced that its next-generation miniaturised wireless sub-retinal implant, PRIMA, has received authorisation from the French regulatory agency, Agence nationale de sécurité du médicament et des produits de santé (ANSM), to start a feasibility clinical study in patients with advanced dry age-related macular degeneration (dry-AMD). Khalid Ishaque, Chief Executive Officer of Pixium Vision, a company developing bionic vision systems to enable patients who have lost their sight to lead more independent lives, commented: “PRIMA enters an exciting phase of its development, with a first patient expected to be implanted before year end.” www.pixium-vision.com    
Tags: sub-retinal implant